---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-020829"
form_type: "8-K"
ticker: "MRAI"
cik: "0001844392"
company_name: "Marpai, Inc."
filed_at: "2022-11-01T23:59:59+00:00"
generated_at: "2026-06-22T19:18:24.908394+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Marpai closes acquisition of Maestro Health, doubling its size in self-funded TPA market

## Summary
- Acquisition closed Oct 31, 2022, doubles Marpai's customer and member count.
- Maestro serves over 80 self-insured employers; combined company covers over 40,000 employees.
- Maestro adds clinical care management and pharmacy cost containment saving up to 75% on specialty meds.
- Integration of Maestro brand and systems expected by early 2023.
- Marpai CEO expects acquisition to transform cost and outcome curves in self-funded healthcare.

## SEC filing metadata
- accession: 0000950170-22-020829
- form_type: 8-K
- ticker: MRAI
- cik: 0001844392
- company_name: Marpai, Inc.
- filed_at: 2022-11-01T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1844392/000095017022020829/0000950170-22-020829-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1844392/000095017022020829/mrai-20221101.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-020829
- JSON: https://secwatch.observer/filing/0000950170-22-020829.json
- Plain text: https://secwatch.observer/filing/0000950170-22-020829.txt

## Key facts
- M&A Transactions
  Marpai, Inc. completed an acquisition involving Maestro Health, LLC (closed 2022-10-31).
  - Action: acquisition
  - Counterparty: Maestro Health, LLC
  - Closing: 2022-10-31
  source text: On October 31, 2022, Marpai, Inc. (the “Company”) consummated the previously announced acquisition (the “Acquisition”) of Maestro Health, LLC (“Maestro Health”), a Delaware limited liability company, pursuant to the terms of the Membership Interest Purchase Agreement executed by and among the Company, X.L. America, Inc., a Delaware corporation, Seaview Re Holdings Inc., a Delaware corporation, and AXA S.A., a French société anonyme.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1844392/000095017022020829/0000950170-22-020829-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.